Key facts
- It has raised $201.0M; the latest was Later Stage VC in Aug 2024.
- Notable investors include General Catalyst, Gaingels, Samsung NEXT Ventures, Greycroft, TriplePoint Capital — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Redesign Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Redesign Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Redesign Health
Operator of a mission-driven healthcare firm intended to launch and support healthcare companies. The company's platform helps develop technologies, tools, and information that lower the barriers to change across the industry and helps founders raise funds and get expert support, enabling the healthcare ecosystem to accelerate the process, including cancer care, teleradiology, COVID-19 testing, and metabolic health.
- Sector
- Financial Services
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 250
- Website
- redesignhealth.com/
- Ownership
- Privately Held (backing)
Redesign Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Redesign Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Redesign Health in its N-PORT filings yet. We sweep new filings monthly.